{"Adalimumab":{"RelatedTo":["Tumor necrosis factor","High affinity immunoglobulin gamma Fc receptor I","Low affinity immunoglobulin gamma Fc region receptor III-B","Complement C1s subcomponent","Complement C1r subcomponent","Complement C1q subcomponent subunit A","Complement C1q subcomponent subunit B","Complement C1q subcomponent subunit C","Low affinity immunoglobulin gamma Fc region receptor III-A","Low affinity immunoglobulin gamma Fc region receptor II-a","Low affinity immunoglobulin gamma Fc region receptor II-b"],"Synonym":["Ig gamma-1 chain C region"],"SuperCategory":"Molecular entity","Comment":"taken from DrugBank","Id":"DB00051","Curator":"ab","Has role":"Drug","DefiningCitation":"http:\/\/www.drugbank.ca\/drugs\/DB00051","Definition":"Anti-TNF antibody, expressed in mammalian cell culture, 1330 residues, MW"}}